Camelot Portfolios LLC grew its holdings in HCA Healthcare Inc (NYSE:HCA) by 10.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,215 shares of the company’s stock after buying an additional 210 shares during the period. Camelot Portfolios LLC’s holdings in HCA Healthcare were worth $327,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in HCA. Schroder Investment Management Group boosted its stake in shares of HCA Healthcare by 215.7% during the 2nd quarter. Schroder Investment Management Group now owns 1,328,422 shares of the company’s stock worth $179,562,000 after purchasing an additional 907,658 shares during the period. Jacobs Levy Equity Management Inc. boosted its stake in shares of HCA Healthcare by 11.4% during the 2nd quarter. Jacobs Levy Equity Management Inc. now owns 12,260 shares of the company’s stock worth $1,657,000 after purchasing an additional 1,250 shares during the period. Johnson Investment Counsel Inc. boosted its stake in shares of HCA Healthcare by 70.6% during the 2nd quarter. Johnson Investment Counsel Inc. now owns 4,156 shares of the company’s stock worth $561,000 after purchasing an additional 1,720 shares during the period. Private Advisor Group LLC boosted its stake in shares of HCA Healthcare by 38.9% during the 2nd quarter. Private Advisor Group LLC now owns 2,245 shares of the company’s stock worth $304,000 after purchasing an additional 629 shares during the period. Finally, Ellington Management Group LLC purchased a new stake in HCA Healthcare in the 2nd quarter valued at about $284,000. 69.43% of the stock is owned by hedge funds and other institutional investors.
In related news, SVP Christopher F. Wyatt sold 3,900 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $134.74, for a total transaction of $525,486.00. Following the sale, the senior vice president now directly owns 27,353 shares of the company’s stock, valued at $3,685,543.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jon M. Foster sold 19,477 shares of the stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $132.35, for a total transaction of $2,577,780.95. Following the sale, the insider now directly owns 10,015 shares in the company, valued at $1,325,485.25. The disclosure for this sale can be found here. Insiders sold a total of 48,511 shares of company stock worth $6,592,095 over the last ninety days. Insiders own 2.70% of the company’s stock.
Several equities research analysts have recently commented on HCA shares. Bank of America upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a report on Friday, December 6th. Deutsche Bank started coverage on shares of HCA Healthcare in a report on Friday, January 3rd. They issued a “buy” rating and a $140.00 price target for the company. ValuEngine upgraded shares of HCA Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $157.00 to $186.00 and gave the company an “overweight” rating in a report on Friday, December 20th. Finally, Barclays boosted their price target on shares of HCA Healthcare from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Wednesday, October 30th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $156.07.
Shares of HCA Healthcare stock opened at $147.77 on Friday. HCA Healthcare Inc has a 12-month low of $110.31 and a 12-month high of $150.17. The firm has a market capitalization of $50.17 billion, a price-to-earnings ratio of 15.12, a PEG ratio of 1.13 and a beta of 0.92. The firm’s 50 day simple moving average is $145.42 and its two-hundred day simple moving average is $133.36.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $2.23 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.13 by $0.10. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The business had revenue of $12.69 billion for the quarter, compared to analyst estimates of $12.48 billion. During the same quarter in the prior year, the business posted $2.16 EPS. HCA Healthcare’s revenue for the quarter was up 10.9% compared to the same quarter last year. Equities research analysts anticipate that HCA Healthcare Inc will post 10.53 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 2nd were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.08%. The ex-dividend date was Friday, November 29th. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.